In our previous study, we showed that the oncogenic activity of δ-catenin in prostate cancer is mediated by promoting E-cadherin processing and the subsequent transactivation of β-catenin-mediated signaling5. The gene discussed is CDH1; the disease is Familial prostate cancer.